Anika Therapeutics (NASDAQ:ANIK) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Anika Therapeutics missed estimated earnings by 20.0%, reporting an EPS of $-0.36 versus an estimate of $-0.3.
Revenue was up $1.23 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 10.25% drop in the share price the next day.
Here's a look at Anika Therapeutics's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.24 | -0.25 | -0.23 | -0.36 |
| EPS Actual | -0.21 | -0.05 | -0.12 | -0.11 |
| Revenue Estimate | 37.70M | 37.59M | 37.85M | 32.90M |
| Revenue Actual | 39.62M | 40.26M | 39.66M | 36.69M |
To track all earnings releases for Anika Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
